Here are the key things you need to know about in the NZX markets over the past 24 hours. Changes are as at 3:00 pm and may change when the market closes at 4:45 pm.
WHAT THE NZX 50 INDEX IS DOING
The NZX50 is tracking a -0.7% decline today, leaving the index down -1.3% over the past five sessions. Despite the softness over the week, the benchmark remains +9.7% higher over six months and up +4.2% year-on-year.
THE MAIN GAINERS
There were 31 gainers, though movements among the top NZX50 names were modest at around +1%. Vector Energy (VCT, #11) eased -1% over five days but remains up +31% year-on-year. Property for Industry (PFI, #25) has climbed +15% in the past six months and +12% annually. Channel Infrastructure (CHI, #30) gained +4% over five days, extending its year-on-year rise to +40%. Summerset Group (SUM, #17) lifted +4% for the month but is still down -5% on an annual basis.
Vector
Select chart tabs
THE MAIN DECLINERS
On the downside, 59 stocks declined, with the largest NZX50 falls coming from Fisher & Paykel Healthcare (FPH, #1), Vulcan Steel (VSL, #26), Investore Property (IPL, #47), and SkyCity Entertainment (SKC, #37), each down -2%. F&P Healthcare is off -5% for the month and -3% year-on-year. Vulcan Steel has gained +4% over six months but is down -3% annually. Investore is up +20% over six months and +3% year-on-year. SkyCity rose +10% month-on-month but remains sharply lower, down -44% year-on-year.
Fisher and Paykel Healthcare
Select chart tabs
SMARTSHARES EFTs
| 1-day | 5-day | 6-month | YTD | 1Y | |
| NZ Top 50 ETF (FNZ) | -0.8% | -0.5% | +9.7% | +3.3% | +3.3% |
| NZ Top 10 ETF (TNZ) | +0.1% | +0.9% | +4.7% | -6.1% | -2.9% |
| S/P NZX50 ETF (NZG) | -0.8% | +0.2% | +8.3% | +0.4% | +1.9% |
| NZ Dividend ETF (DIV) | +0.2% | -0.9% | +21.7% | +13.2% | +11.3% |
KEY ANNOUNCEMENTS
EROAD (ERD) has announced a sharpened focus on the growing electronic road user charging (eRUC) opportunity in New Zealand and Australia, supported by governance changes and updated FY26 guidance. The company will prioritise ANZ growth investment while maintaining its North American presence, where sales cycles remain extended. John Scott has been appointed Executive Chair, with Susan Paterson resuming her role as Director and Chair of the People and Culture Committee, while Co‑CEO David Kenneson will step down at the end of October, leaving Mark Heine as sole CEO. Reflecting its strategic shift and the loss of a major North American customer contract in early 2026, EROAD now expects FY26 revenue of $197mln–$203mln, ARR of $175mln–$183mln, and free cash flow margin of 5%–8%.
The NZX (NZX, #46) has confirmed regulatory approval for amendments to its Participant Rules, Derivatives Market Rules, and Clearing & Settlement Rules, along with related procedural changes, to update requirements around business continuity and disaster recovery (BCP). The revisions, which remove existing BCP provisions from the Procedures, will take effect from the 17th of November. To support participants, NZX will also release a new Business Continuity and Disaster Recovery Guidance Note to help interpret and meet obligations under the updated framework.
NZX50 Healthcare Sector
Select chart tabs
Click on the chart title to find more about this sector, including its components.
We welcome your comments below. If you are not already registered, please register to comment.
Remember we welcome robust, respectful and insightful debate. We don't welcome abusive or defamatory comments and will de-register those repeatedly making such comments. Our current comment policy is here.